Lilly perceptions from the cp ALKS board
"When we last spoke with Lechleiter a year ago, he repeated a steadfast refusal to consider a merger with another big drugmaker. Would anyone want Lilly at this point? Given the setbacks of the past year, Lilly is less attractive than ever, not withstanding some pipeline magic that hasn’t been fully disclosed. But Lechleither has literally done little to buy needed time. Perhaps he needs to rethink his mantra."
Maybe on the walk home today? How was the voice mail? Do you feel better now?